Skip to content

Effect of zinc sulphate in papilloma virus

Efficiency of oral zinc sulphate supplement on clearance of cervical human papilloma virus

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210407050882N1
Enrollment
80
Registered
2021-04-15
Start date
2021-04-09
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal papsmear and cervical cytology.

Interventions

Intervention 1: Control group:no medication. Intervention 2: Intervention group: Before starting the study, the subject of research on the relationship between serum zinc levels and the possibility of

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 55 Years

Inclusion criteria

Inclusion criteria: positive HPV DNA test LSIL in pap smear Ascus in pap smear

Exclusion criteria

Exclusion criteria: Pregnancy Breast feeding Immunocompromised state deasie Perior history of cervical cone biopsy or LEEP

Design outcomes

Primary

MeasureTime frame
Effect of oral zinc sulphat(in department variable)in clearance of cervical human papilloma virus (dependent variable). Timepoint: Both groups check their serum zinc levels at start and the end of study,which is before the star of zinc supplement and 30 days after the last dose of zinc for intervention group.Than in both groups do pap smear and cervical HPV typing. Method of measurement: Repeat pap smear and HPV typing in same laborator.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNaghme zandvakili

Oroumia University of Medical Sciences

zandvakilinaghme@gmail.com+98 44 3366 4468

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026